Evidence map›Paper›PMID 16035616›Full record

ArticleClinical & experimental metastasis2004

Carcinoembryonic antigen promotes tumor cell survival in liver through an IL-10-dependent pathway.

J Milburn Jessup, R Samara, P Battle, L M Laguinge

Abstract read
PubMed Publisher
In one paragraph

Article in Clinical & experimental metastasis, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Interleukin 10 promotes immune response by increasing the survival of activated CD8Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine · 2016
    Article
  6. Article
  7. Review
  8. Divergent roles of CD44 and carcinoembryonic antigen in colon cancer metastasis.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2012
    Article
  9. Article
  10. Review
  11. The liver prometastatic reaction of cancer patients: implications for microenvironment-dependent colon cancer gene regulation.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2011
    Article
  12. Article
  13. The prometastatic microenvironment of the liver.Cancer microenvironment : official journal of the International Cancer Microenvironment Society · 2008
    Article
  14. Review
  15. Serum cytokine profile as a potential prognostic tool in colorectal cancer patients - one center study.Reports of practical oncology and radiotherapy : journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

J Milburn JessupDepartment of Oncology, Georgetown University Medical Center, Washington, DC, USA. jmj25@georgetown.edu
R Samara
P Battle
L M Laguinge
Georgetown University · USGeorgetown University Medical Center · USUPMC Hillman Cancer Center · US

Funding

METASTATIC POTENTIAL OF HUMAN COLORECTAL CARCINOMAR01CA042857 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI MISHRA, LOPA · 1986 to 2010
$3.2M
NCI NIH HHS CA42857
6 · The paper itself

Abstract

Most circulating tumor cells die within 24 h of entering the hepatic microvasculature because their arrest initiates an ischemia-reperfusion (I/R) injury that is cytotoxic. Human colorectal carcinomas (CRC) produce the glycoprotein Carcinoembryonic Antigen (CEA) that increases experimental liver metastasis in nude mice. Since CEA induces release of IL-6 and IL-10, we hypothesized that CEA inhibits the I/R injury through a Kupffer cell-mediated cytokine-dependent pathway. We assessed cytokine effects in CRC co-cultured with liver and in vivo. Human CRC prelabeled with fluorescent dyes were incubated with a reoxygenated suspension of ischemic nude mouse liver fragments in a bioreactor. CEA, rhIL-6 or rhIL-10 were either administered to the donor mice prior to hepatic ischemia or during co-culture. Liver donors were athymic nude or iNOS, IL-6 or IL-10 knock out mice. Ischemic-reoxygenated liver kills Clone A CRC through production of nitric oxide (NO) and superoxide anion. Treatment of liver donors with CEA prior to hepatic ischemia inhibited this in vitro cytotoxicity through an IL-10 and Kupffer cell dependent pathway that inhibited NF-kappaB activation, NO production and iNOS upregulation. IL-10 but not IL-6 enhanced CRC survival in nude mouse liver in vivo. Thus, CEA enhanced metastasis by inducing IL-10 to inhibit iNOS upregulation in host liver.

Indexed as

AnimalsCarcinoembryonic AntigenCell SurvivalCoculture TechniquesColorectal NeoplasmsFluorescent DyesHumansInterleukin-10Interleukin-6Kupffer CellsLiverLiver NeoplasmsMaleMiceMice, Inbred C57BLMice, KnockoutCarcinoembryonic AntigenFluorescent DyesInterleukin-10Interleukin-6NF-kappa BNitric OxideNitric Oxide SynthaseNitric Oxide Synthase Type IINOS2 protein, humanNos2 protein, mouseOxygenSuperoxides

Identifiers

PMID16035616
OpenAlexW1965892013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.